✦ LIBER ✦

Impact of Intraportal Donor-Specific Leukocyte Transfusion for Adult ABO-Incompatible Liver Transplantation

✍ Scribed by H. Oya; Y. Sato; S. Yamamoto; H. Nakatsuka; T. Kobayashi; T. Watanabe; Y. Hara; H. Kokai; K. Hatakeyama

Book ID: 116934848
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 120 KB
Volume: 41
Category: Article
ISSN: 0041-1345
DOI: 10.1016/j.transproceed.2008.09.061

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adult ABO-Incompatible Liver Transplanta

Adult ABO-Incompatible Liver Transplantation by Intraportal Transfusion of Donor-Specific Antigen: A Case Report

✍ Y. Sato; S. Yamamoto; H. Oya; H. Nakatsuka; T. Kobayashi; T. Watanabe; Y. Hara; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 407 KB

ABO-Incompatible Adult Living Donor Live

ABO-Incompatible Adult Living Donor Liver Transplantation for Hepatocellular Carcinoma

✍ N. Matsuno; H. Iwamoto; Y. Nakamura; K. Hama; Y. Kihara; O. Konno; Y. Jojima; I. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 66 KB

The Role of Plasmapheresis Therapy for P

The Role of Plasmapheresis Therapy for Perioperative Management in ABO-Incompatible Adult Living Donor Liver Transplantation

✍ T. Ashizawa; N. Matsuno; T. Yokoyama; Y. Kihara; K. Kuzuoka; S. Taira; O. Konno; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 64 KB

The impact of donor type and ABO incompa

The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantation

✍ Zejing Wang; Mohamed L. Sorror; Wendy Leisenring; Gary Schoch; David G. Maloney; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB

B-cell surface marker analysis for impro

B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation

✍ Hiroto Egawa; Katsuyuki Ohmori; Hironori Haga; Hiroaki Tsuji; Kimiko Yurugi; Aya 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB 👁 2 views

Although the effectiveness of rituximab has been reported in ABO blood group (ABO)-incompatible (ABO-I) organ transplantation, the protocol is not yet established. We studied the impact of the timing of rituximab prophylaxis and the humoral immune response of patients undergoing ABO-I living donor l

The Impact Of Donor Type And ABO Incompa

The Impact Of Donor Type And ABO Incompatibility On Transfusion Requirements After Nonmyeloablative Hematopoietic Cell Transplantation (HCT)

✍ Z. Wang; M.L. Sorror; W. Leisenring; G. Schoch; D. Maloney; B.M. Sandmaier; R. S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 76 KB